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DNA Deamination Mediates Innate Immunity
to Retroviral Infection
major targets for HIV infection in vivo) and has been
shown to be a potent inhibitor of Vif-deficient HIV
(Sheehy et al., 2002).
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Michael S. Neuberger,1 and Michael H. Malim2 CEM15/APOBEC3G is a member of the APOBEC fam-
ily of proteins of which the RNA editing protein APO-1Medical Research Council Laboratory of
Molecular Biology BEC1 is the founder (Teng et al., 1993; Jarmuz et al.,
2002). Similarity to APOBEC1 suggested that CEM15/Hills Road
Cambridge CB2 2QH APOBEC3G might also function by deaminating cyto-
sine in RNA—either a host message or the viral RNAUnited Kingdom
2 Department of Infectious Diseases genome—although it has not been demonstrated to
have any RNA editing activity.Guy’s, King’s and Street Thomas’ School of
Medicine However, CEM15/APOBEC3G has been shown to be
able to act as a DNA mutator in E. coli, with the mutationsKing’s College London
London SE1 9RT attributable to dC→dU deamination (Harris et al., 2002).
This led us to speculate (Harris et al., 2003) that CEM15/United Kingdom
APOBEC3G triggers the block to retroviral infectivity by
deaminating dC→dU in the first (minus)-strand of the
viral cDNA during a postentry step of its lifecycle. Here,Summary
this hypothesis is tested using a helper virus-dependent
MLV-based assay system. We show that MLV producedCEM15/APOBEC3G is a cellular protein required for
using cells expressing CEM15/APOBEC3G has a dimin-resistance to infection by virion infectivity factor (Vif)-
ished infectivity as monitored using fluorescent protein-deficient human immunodeficiency virus (HIV). Here,
encoding genes embedded in viral sequence. Moreover,using a murine leukemia virus (MLV)-based system,
this correlated with the introduction of a phenomenallywe provide evidence that CEM15/APOBEC3G is a DNA
high mutation load into the viral cDNA, nearly all thedeaminase that is incorporated into virions during viral
mutations being G→A substitutions as read-out on theproduction and subsequently triggers massive deami-
viral plus (genomic) strand. This result is only consistentnation of deoxycytidine to deoxyuridine within the ret-
with CEM15/APOBEC3G causing massive deaminationroviral minus (first)-strand cDNA, thus providing a
of dC→dU in the viral minus (first cDNA) strand, thusprobable trigger for viral destruction. Furthermore, HIV
establishing CEM15/APOBEC3G as the critical compo-Vif can protect MLV from this CEM15/APOBEC3G-
nent of this innate defense mechanism. Furthermore,dependent restriction. These findings imply that tar-
HIV Vif expression is able to counteract the CEM15/geted DNA deamination is a major strategy of innate
APOBEC3G effect on MLV infectivity indicating that Vifimmunity to retroviruses and likely also contributes
serves to overcome a general mode of innate antiretrovi-to the sequence variation observed in many viruses
ral defense that is mediated by DNA deamination.(including HIV).
Results
Introduction
CEM15/APOBEC3G Can Deaminate DNA
Productive infection by HIV depends on the virus-
We first used a biochemical assay to assess whether
encoded protein Vif (Fisher et al., 1987; Strebel et al.,
CEM15/APOBEC3G was directly capable of deaminat-
1987). Vif expression is necessary only in the virus-pro-
ing DNA in vitro. Purified, recombinant CEM15/APO-
ducing cell; in its absence, infection of a subsequent
BEC3G was indeed able to deaminate dC→dU in a sin-
target cell terminates at a postentry step through the
gle-strand DNA oligonucleotide substrate (Figure 1), an
action of an innate antiviral mechanism (Sova and Vol-
activity that has recently also been observed with other
sky, 1993; von Schwedler et al., 1993; Simon and Malim,
APOBEC family members, AID (Bransteitter et al., 2003;
1996; Madani and Kabat, 1998; Simon et al., 1998a).
Chaudhuri et al., 2003) and APOBEC1 (Figure 1A, lane
How Vif mediates HIV infectivity is not yet known and
1 and Petersen-Mahrt and Neuberger, 2003).
few clues are apparent in its amino acid sequence as it
is highly variable amongst HIV isolates and shows little
MLV Produced in CEM15/APOBEC3G Cells Hassimilarity to other proteins. But, central to this infection
Diminished Infectivityrestriction mechanism is the human protein CEM15/
In addition to regulating the infectivity of lentivirusesAPOBEC3G, which is expressed in human T cells (the
such as HIV, earlier work suggested that Vif also stimu-
lates infection and replication of the distantly related
*Correspondence: rsharris@mrc-lmb.cam.ac.uk oncoretrovirus MLV (Simon et al., 1998b). This raised
3 These authors contributed equally to this work. the possibility that CEM15/APOBEC3G might also be4 Present Address (beginning August 1, 2003): Department of Bio-
able to impede infection by MLV. We therefore soughtchemistry, Molecular Biology and Biophysics, University of Minne-
to develop a helper virus-dependent, MLV-based assaysota, 6-155 Jackson Hall, 321 Church Street SE, Minneapolis, MN
55455. system. Stocks of recombinant MLV encoding yellow
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Figure 2. CEM15/APOBEC3G Diminishes MLV Infectivity
293T-derived stocks of YFP-encoding MLV produced by cotransfec-
tion with a control vector or with 1 g or 3 g of pCEM15:HA were
used in challenges of Mus dunni fibroblasts across a range of input
inocula (normalized units of RT). Similar data were obtained in paral-Figure 1. DNA Deamination by CEM15/APOBEC3G
lel challenges of N-3T3 cells (data not shown).(A) Deamination of dC within a single-stranded oligonucleotide by
purified His-tagged CEM15/APOBEC3G (as well as by recombinant
APOBEC1 control) was monitored by subsequent treatment of the been infected but with the GFP gene having been ren-
oligonucleotide with uracil-DNA glycosylase (UDG)/NaOH which dered nonfunctional by CEM15/APOBEC3G-induced
breaks the oligonucleotide at the site of dC→dU deamination (illus-
mutations. Target cells that were negative (-lo) for GFPtrated to the left of the gel image).
expression (as well as their GFP-hi counterparts) were(B) Western blot of E.coli extracts expressing recombinant CEM15/
therefore isolated by flow cytometry and the retroviralAPOBEC3G (upper band, lane 1) or a control plasmid (lane 2).
DNA present in cell lysates amplified by PCR, cloned,
and sequenced.
A comparison of the GFP gene sequences recoveredfluorescent protein (YFP) were produced in 293T cells
from GFP-lo cells revealed a striking level of plus-strand(a line not expressing CEM15/APOBEC3G; Sheehy et
G→A transition mutation, but only when the input virusal., 2002) in the presence or absence of transfected
was derived from CEM15/APOBEC3G-expressing cellsCEM15/APOBEC3G. A range of viral inocula as mea-
(Figures 3B and 3C; Figure 4). A total of 435 G→A transi-sured by reverse transcriptase (RT) activity was then
tions were found distributed over 86 dG residues in 38used to challenge murine fibroblasts, and productive
sequences (27,740 bp) yielding a mutation frequencyinfection was monitored48 hr later by flow cytometric
of 1.5 mutations per 100 bases. In contrast, only threeanalysis. As seen in Figure 2, the presence of CEM15/
separate G→A transitions were found in 47 sequencesAPOBEC3G had a dose-dependent inhibitory effect on
(34,310 bp) derived from the GFP-lo sorted reporter cellsMLV infection that was clearly apparent at all levels of
that had been challenged with MLV derived from a non-input inocula (e.g., for inocula that contained 300 relative
CEM15/APOBEC3G expressing producer cell line. Bothunits of RT, the presence of CEM15/APOBEC3G during
sequence cohorts contained six other base substitutionvirus production caused about a 10-fold reduction of
mutations likely attributable to RT or PCR errors, al-infectivity). Thus, the antiretroviral property of CEM15/
though two deletions were also detected in the G→AAPOBEC3G can be extended to the simple (non-vif en-
transition-littered sequences.coding) retrovirus, MLV.
The level of mutation was so high (a median of 11.5
mutations per virus-derived 730-nucleotide GFP gene
G→A Mutation of MLV DNA Replication sequenced) that we anticipated that mutations would
Intermediates Following Virus Production be evident even in DNA obtained from GFP-positive
on CEM15/APOBEC3G Cells target cells. This was indeed the case. A surprising total
To begin to assess whether retroviral cDNA might be of 299 G→A transition mutations were found distributed
the physiological substrate for the DNA deaminating over 47 retroviral cDNAs obtained from the GFP-hi cells
activity of CEM15/APOBEC3G, a GFP-encoding MLV that were sorted from the population challenged with
was produced in 293T cells stably expressing (or not MLV-GFP produced from CEM15/APOBEC3G-express-
expressing) human CEM15/APOBEC3G. As in the YFP ing cells (Figures 3B and 3C; Figure 4). Thus, even with
experiments, expression of CEM15/APOBEC3G in the enrichment for the brightest fluorescing cells, 91% (43/
producer cell resulted in a substantial inhibitory effect 47) of the amplified sequences harbored mutations
on MLV infection, as judged by diminished fluorescence yielding a frequency of 0.9 mutations per 100 bases.
of the reporter cells (Figure 3A). Although when compared closely to mutations in se-
Reasoning that dC→dU deamination of the retroviral quences derived from GFP-lo cells, the types of muta-
reverse transcripts (cDNA) could give rise to inactivating tions apparent in sequences from GFP-hi cells are signif-
mutations of the GFP gene, we speculated that some icantly different (e.g., creating proportionately fewer
amino acid changes).of the GFP-negative target cells could nevertheless have
DNA Deamination Mediates Innate Viral Immunity
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Figure 3. Mutation of Retroviral First-Strand cDNA by CEM15/APOBEC3G
(A) GFP fluorescence of target 293T cells 48h after challenge with equivalent levels of MLV-GFP virions derived from 293T cells stably
expressing CEM15/APOBEC3G or a control plasmid. The percentages of cells within the GFP-positive window are indicated.
(B) Profiles of the relative positions of the G→A transition mutations apparent in 12 representative 730 bp GFP sequences derived from GFP-
lo and GFP-hi populations of cells challenged with MLV-GFP grown on CEM15/APOBEC3G-expressing cells or nonexpressing controls. Two
independently derived CEM15/APOBEC3G clones (and two independent controls) were analyzed for each experiment (separated by a space).
The G→A transitions are depicted by vertical lines whereas other single nucleotide substitutions (20 in total) are indicated by lollipops and
thick, horizontal black bars represent the two deletions detected. Note that each pair of panels (lo and hi) represents sequences recovered
from 293T target cells, but the viral stocks used in each experiment (each panel pair) were derived from independent clones either expressing
or not expressing CEM15/APOBEC3G.
(C) A comparison of the extent of GFP mutation in the different samples. The pie charts depict the proportion of MLV sequences carrying the
indicated number of mutations within the 730 bp interval sequenced. The total number of sequences determined in each data set is indicated
in the center.
The mutational onslaught experienced by the GFP population, presumably reflecting multiple infections of
individual cells.gene generates some obviously nonfunctional variants
(Figure 4). Although, these were especially apparent in The dramatic mutation of retroviral cDNA seen here
is strictly dependent on CEM15/APOBEC3G. Mutatedthe GFP-lo populations, probable nonfunctional variants
were still evident in cDNAs obtained from the GFP-hi GFP genes were rarely obtained from target cells in-
Cell
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Figure 4. Retroviral cDNA Mutation Spectra
(A) Mutations detected amongst GFP sequences amplified from GFP-lo enriched target cell populations. Mutations derived from MLV-GFP
challenged target cells in which the viral stocks used were grown in CEM15/APOBEC3G-expressing cells are depicted above the 730 bp
consensus (the viral plus or coding strand is shown) and those derived from vector-expressing cells are shown below. Deletions are boxed.
(B) GFP mutations from GFP-hi enriched cell populations.
fected with virus produced in the absence of CEM15/ evident from CEM15/APOBEC3G-induced mutation in
the rpoB gene of E. coli (Harris et al., 2002).APOBEC3G. Specifically, a total of only 9 and 6 muta-
tions were observed in 47 and 48 sequences from the
GFP-lo and -hi sequences respectively, an overall fre-
CEM15/APOBEC3G Is Incorporated
quency of only 0.012 mutations per 100 bases (Figures
into MLV Virions
3B and 3C; Figure 4). This background mutation differed
The CEM15/APOBEC3G-mediated suppression of HIV
from CEM15/APOBEC3G-triggered mutation not just in
infection is thought to be accomplished by protein trans-
terms of frequency (more than 50-fold), but also in terms
ferred as a virion component from virus producing cells
of pattern (not focusing on major hotspots) and base
into target cells (Sheehy et al., 2002). To show that a
substitution types (less than half are G→A transitions).
similar mechanism could apply in the MLV system used
here, viral particles were recovered from culture super-
The CEM15/APOBEC3G Mutational Bias
natants produced in the presence or absence of CEM15/
When viruses were produced from CEM15/APOBEC3G-
APOBEC3G and subjected to immunoblot analysis (Fig-
expressing cells, virtually all the mutations (734 out of
ure 6A). As seen in lane 2, CEM15/APOBEC3G is indeed
744) were G→A transitions as judged on the viral plus-
incorporated into MLV virions. This presumably ensures
strand (Figure 5A). Since both genetic (Harris et al., 2002)
association with reverse transcription complexes in
and biochemical (Figure 1) evidence indicates that
newly infected cells and proximity to nascent cDNA sub-
CEM15/APOBEC3G deaminates dC→dU in DNA, the
strates for the execution of dC deamination.
G→A transitions detected in the PCR-amplified GFP
genes can only be attributed to CEM15/APOBEC3G-
mediated dC→dU deamination in the retroviral minus HIV Vif Can Counteract the CEM15/APOBEC3G-
Dependent Diminution of MLV Infectivity(first)-strand cDNAs.
Interestingly, the distribution of mutations along the Finally, because CEM15/APOBEC3G-mediated inhibi-
tion of HIV infection is counteracted by Vif, we alsoGFP gene was noticeably nonrandom. The great major-
ity of transition mutations attributable to deamination wished to test whether this held true for MLV. Coexpres-
sion of Vif in CEM15/APOBEC3G-expressing cells (eithertargeted to dC residues, including those piled up at
major hot spots, are preceded by a 5-dT/dC (pyrimi- transiently or stably) was able to rescue much of the
productive MLV infection as monitored by fluorescencedine)-dC consensus (Figure 5B). This specificity accords
well with the context preference that was previously (Figures 6B and 6C).
DNA Deamination Mediates Innate Viral Immunity
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Figure 5. Nature and Local Preferences of CEM15/APOBEC3G Mu-
tation
(A) Nucleotide substitution preferences for the entire set of GFP
mutations detected in target cells infected with MLV-GFP that had
been grown on a CEM15/APOBEC3G-expressing producer cells in
comparison to those detected in target cells infected with MLV-
GFP grown on a vector-expressing producer cells.
Figure 6. CEM15/APOBEC3G Is Packaged into MLV Particles and(B) Delineation of the preferred local sequence context for CEM15/
HIV Vif Is Able to Inhibit Its FunctionAPOBEC3G-mediated dC deamination in MLV-GFP. All 734 mutated
(A) YFP-encoding MLV virions were purified from cells (Figure 2)positions were aligned with respect to the dC residue targeted for
that did not (left lane) or did express CEM15/APOBEC3G (right lane)deamination on the minus (first)-strand cDNA and the frequency (as
and analyzed by immunoblotting using antibodies specific for MLVa percentage) with which each of the four bases is found at adjacent
Gag or CEM15/APOBEC3G (HA epitope).positions was calculated.
(B) HIV Vif diminishes CEM15/APOBEC3G-mediated immunity to
YFP-encoding MLV as monitored using the transient expression
system (as in Figure 2) in the presence of pCEM15:HA (3 g) withDiscussion or without pcVIF (1 g).
(C) Restoration of infectivity of CEM15/APOBEC3G-exposed MLV-
The results described here indicate that CEM15/APO- GFP by expression of HIV Vif during viral stock production from
293T cells stably expressing CEM15/APOBEC3G (as in Figure 3A).BEC3G packaged in progeny virions is carried forward
The marginal restoration of infectivity in experiment 2 correlates withinto target cells where it acts to deaminate dC→dU in
the approximately 3-fold higher expression of CEM15/APOBEC3G inthe minus (first)-strand cDNA of the retrovirus.
this cell line over that of the cells used in experiment 1.How might such CEM15/APOBEC3G-mediated DNA
deamination of reverse transcripts contribute to innate
immunity during normal retroviral infection in vivo? One
ated dC→dU deamination in first-strand cDNA that is readpossibility is that the level of mutation achieved is (as
out in the experimental system used here in terms of G→Amay be the case in the experimental system used here)
hypermutation of the plus strand of DNA could functionso high that it jeopardizes viral expansion (Figure 7, left
under physiological conditions to limit the spread of viralschematic). Indeed, hypermutation has been described
infection by triggering a uracil-based excision pathway.in HIV and is typically characterized by excessive G→A
The concept established here of an innate nucleic acidtransitions (Vartanian et al., 1994; Janini et al., 2001).
deamination mechanism may well predate the adaptiveMoreover, it was shown very recently that this bias is
program of antibody gene diversification (Neuberger etparticularly clear in Vif-deficient HIV (Lecossier et al.,
al., 2003) and could easily apply to other types of viruses.2003).
This defense mechanism seems also a likely contributorAlternatively, the CEM15/APOBEC3G-mediated block-
to viral sequence variation.ade of HIV infection has been shown to be accompanied
by a failure to accumulate retroviral cDNAs in target
Experimental Procedures
cells (Simon and Malim, 1996). This is consistent with
the idea that, rather than simply leading to a massive Plasmids and Cells
The pHIT60, pczVSV-G, pCFG2fEYFPf, and pCEM15:HA vectorsaccumulation of viral cDNA mutations, dC→dU deami-
have been described (Bock et al., 2000; Sheehy et al., 2002). pcVIFnation of retroviral first strand could trigger ablation of
is a pBC12-based vector containing the HIV-1IIIB vif gene as an XbaI-viral infection since the presence of uracil in the first-
SalI restriction fragment and four downstream copies of the M-PMVstrand cDNA could recruit components of the base exci-
CTE. MLV-GFP was the kind gift of F. Randow (Cambridge, UK). A
sion repair pathway resulting in the severance of viral nonepitope-tagged human CEM15/APOBEC3G cDNA (Harris et al.,
replication intermediates (Figure 7, right schematic). 2002) was subcloned using PCR into pIRES-Zeo (Clontech). 293T
cell derivatives stably expressing CEM15/APOBEC3G were selectedThus, it may well be that the CEM15/APOBEC3G-medi-
Cell
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for 48 hr, and examined by flow cytometry (Becton Dickinson)
using mock-infected cells as negative controls (Bock et al., 2000).
Retroviral DNA Sequence Analyses
DNA (Qiagen) was purified from populations of GFP-lo and GFP-hi
cells isolated by flow cytometry (Cytomation). Gates were estab-
lished such that only the dullest (GFP-lo) and brightest (GFP-hi) one
percent of all cells was collected. A 98% enrichment of the desired
populations was achieved as judged by reanalysis using a different
FACS. DNA was subject to high-fidelity PCR (Pfu Turbo DNA poly-
merase, Stratagene) using oligonucleotides 5-TAGACGGCATCG
CAGCTTGGA and 5-CTGGTGATATTGTTGAGTCA, gel-purified and
cloned using internal HindIII and NotI restriction sites. The resulting
730 bp fragment contained the entire GFP coding sequence (1 to
721, Figure 3). Sequences bearing an identical set of mutations were
counted only once. We cannot exclude the possibility that some
clones are dynastically related (causing overcounting of some muta-
tions) although this is unlikely to introduce major skewing since the
experiments were performed with a replication-deficient virus and
the same distributions of hotspots was identified in independent
sets of sequences using virus produced from independent CEM15/
APOBEC3G-expressing producer cells.
Virion Protein Precipitations
MLV particles were isolated from culture supernatants by centrifuga-
tion at 20,000  g for 60 min. Pellets were resolved by SDS-PAGE
and subjected to immunoblot analysis using a goat anti-MLV Gag
antiserum (Quality Biotech Inc.) or an anti-HA monoclonal antibody
(Covance), HRP-conjugated secondary antibodies and chemilumi-
nescence.
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